RECENT PAPERS REVIEWS Michel Mittelbronn Neuromuscular disease: 2023 update Marta Margeta Multiple sclerosis: 2023 update Tanja Kuhlmann, Jack Antel David S. Priemer, Daniel P. Perl ORIGINAL PAPERS Susana Boluda, Karima Mokhtari, Bruno Mégarbane, Djillali Annane, Bertrand Mathon, Albert Cao, Clovis Adam, Alexandre Androuin, Franck Bielle, Guy Brochier, Frédéric Charlotte, Lydia Chougar, Khalid Hamid El Hachimi, Marc Eloit, Stéphane Haïk, Dominique Hervé, Amal Kasri, Valentin Leducq, Stéphane Lehéricy, Etienne Levavasseur, Christian Lobsiger, Geoffroy Lorin de La Grandmaison, Isabelle Malet, Isabelle Malissin, Stéphane Marot, Serge Marty, Philippe Pérot, Isabelle Plu, Annick Prigent, Lev Stimmer, Marie-Claude Potier, Anne-Geneviève Marcelin, Benoît Delatour, Charles Duyckaerts, Danielle Seilhean Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients Núria Vidal Robau, Gabriela Caballero, Ivan Archilla, Andrea Ladino, Sara Fernández, Valentín Ortiz-Maldonado, Montserrat Rovira, Marta Gómez-Hernando, Julio Delgado, María Suárez-Lledó, Carlos Fernández de Larrea, Olga Balagué, Gerard Frigola, Abel Muñoz, Estrella Ortiz, Teresa Ribalta, Miguel J. Martinez, Maria Angeles-Marcos, Marta Español-Rego, Azucena González, Daniel Benitez-Ribas, Eugenia Martinez-Hernandez, Pedro Castro, Iban Aldecoa MEETING ABSTRACTS The Canadian Association of Neuropathologists - Association canadienne des neuropathologistes (CANP-ACNP) |
|
Dear colleagues, let’s talk about sustainability today. The first three years of our successful pioneering work under the lead of Werner Paulus is done, heavy tasks have been lifted mainly by the team in Münster with the strong support of many colleagues of the current editorial board. Thank you all so much for your efforts! During multiple application processes (e.g. pubmed, medline) to increase the visibility of FNP, it became however more and more evident that FNP had to come up with a vision how to make FNP sustainable not only with regard to the expected increase in workload of scientific paper handling, but also the organization of IT infrastructure, legal or logistic issues – just to name a few – affecting the entire production line without having a publisher in our back (which is of course one of our key values). Therefore, the decision was taken to appoint a second Editor-in-chief in a different country. With this, I would like to express my gratitude to the entire FNP editorial board for their trust and David Louis for organizing the election process – I am full of energy to serve FNP as additional Editor-in-chief from now on, together with Werner Paulus. As also multiple important international neuropathology societies have recently expressed their trust in our concept and values, the FNP board feels the high responsibility in further promoting the most important information in the central academic pillars – diagnostic, research and teaching – of our domain. My aim is to be a highly accessible and reactive Editor, so don’t hesitate to discuss personally with me or share new ideas important for the positive development of our domain and journal. Over the next weeks, we aim at paralleling the infrastructures of FNP to be ready for the expected increase in workload associated with our goal to be even more visible in pubmed and other related repositories in the near future. |
Michel Mittelbronn |
GENERAL INFORMATION Why is the journal called Free Neuropathology and what exactly does free mean?
Free for authors means that there is no article processing fee. If you’d like to make up your own mind about this project, head to the journal’s website at freeneuropathology.org where you’ll find out more about our publication model, our editorial board, FAQ, free access to all papers published so far, and more. |
FOLLOW US |
|||
If you wish to subscribe to this newsletter, please |